Rare diseases
Investigational molecules
Locations
Sycamore House, Leyden Road, SG1 2BP, United Kingdom
Clinical research activity is centered on Gaucher disease type 1, with attention to the long-term management of this inherited lysosomal storage disorder. The sponsor’s trial portfolio reflects interest in sustained disease control and ongoing safety monitoring in this rare metabolic condition.
Work in this area is associated with the evaluation of durable clinical benefit in a chronic orphan disease setting.
Spur Therapeutics Limited runs clinical trials in conditions such as Gaucher's disease type I, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
SpainSpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
